Genetic :: New genetic test developed at Emory advances detection and diagnosis of muscular dystrophy

A new genetic test targeting the most common types of muscular dystrophy — those caused by mutations in the dystrophin gene — is far quicker with greater accuracy and sensitivity than existing tests. It can be used to confirm clinical diagnoses, to test female family members who may be carriers, and to perform prenatal testing.

Rheumatoid Arthritis :: Enbrel safety data for up to 8 years in patients with juvenile rheumatoid arthritis

Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the presentation of additional data that showed that the safety profile of Enbrel? (etanercept) was maintained with long-term use in patients with moderate-to-severe juvenile rheumatoid arthritis (JRA) who completed up to eight years of therapy.

Fitness :: To keep fit in space, train like an athlete

If one part of your car isn’t properly maintained, it can affect how the entire vehicle runs ? especially if you’re taking a long trip. The same can be said for the human body. That?s why, when it comes to fitness in space, it?s important to create a program addressing the whole system, parts included.

Health :: Possible new strategy for treating rare muscle disease, kidney disorders

Based on clues provided by a study with transgenic mice, a research group at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has developed a strategy that will be tested as the first treatment for people with hereditary inclusion body myopathy (HIBM), a rare, degenerative muscle disease.

Genome :: Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders

Based on clues provided by a study with transgenic mice, a research group at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has developed a strategy that will be tested as the first treatment for people with hereditary inclusion body myopathy (HIBM), a rare, degenerative muscle disease.

Incontinence :: Minimally invasive device shows promise in treating female urinary incontinence

A minimally invasive device for treating recurrent stress urinary incontinence in women has been shown to be safe and effective in early clinical trials and is now under review by the US Food and Drug Administration (FDA), says Emory University School of Medicine urologist and trial co-principal investigator Niall Galloway, MD.

West Nile virus :: UT Southwestern joins national clinical trial to uncover long-term effects of West Nile virus

UT Southwestern Medical Center has joined a national clinical trial to identify the long-term health effects of West Nile virus infection and to learn more about the disease’s progression, symptoms and mortality.